- Home
- Publications
- Publication Search
- Publication Details
Title
Harnessing DNA Double-Strand Break Repair for Cancer Treatment
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-12-10
DOI
10.3389/fonc.2019.01388
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A historical reflection on our understanding of radiation-induced DNA double strand break repair in somatic mammalian cells; interfacing the past with the present
- (2019) Atsushi Shibata et al. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
- Targeting DNA Double-Strand Break Repair Pathways to Improve Radiotherapy Response
- (2019) Mahmoud Toulany Genes
- Aberrations in DNA repair pathways in cancer and therapeutic significances
- (2019) Akira Motegi et al. SEMINARS IN CANCER BIOLOGY
- Genetic Screens Reveal FEN1 and APEX2 as BRCA2 Synthetic Lethal Targets
- (2019) Kristen E. Mengwasser et al. MOLECULAR CELL
- MRN (MRE11-RAD50-NBS1) Complex in Human Cancer and Prognostic Implications in Colorectal Cancer
- (2019) Yiling Situ et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- NBS1 promotes the endonuclease activity of the MRE11‐RAD50 complex by sensing CtIP phosphorylation
- (2019) Roopesh Anand et al. EMBO JOURNAL
- PARP Inhibitors: Extending Benefit Beyond BRCA-Mutant Cancers
- (2019) Patrick G. Pilié et al. CLINICAL CANCER RESEARCH
- The BRCA Tumor Suppressor Network in Chromosome Damage Repair by Homologous Recombination
- (2019) Weixing Zhao et al. Annual Review of Biochemistry
- Overall survival and updated progression-free survival outcomes in a randomized phase II study of combination cediranib and olaparib versus olaparib in relapsed platinum-sensitive ovarian cancer
- (2019) J F Liu et al. ANNALS OF ONCOLOGY
- Cediranib suppresses homology-directed DNA repair through down-regulation of BRCA1/2 and RAD51
- (2019) Alanna R. Kaplan et al. Science Translational Medicine
- Overcoming Treatment Toxicity through Sequential Therapy
- (2019) Jan Benada et al. CANCER CELL
- Sequential Therapy with PARP and WEE1 Inhibitors Minimizes Toxicity while Maintaining Efficacy
- (2019) Yong Fang et al. CANCER CELL
- High expression of MRE11 correlates with poor prognosis in gastric carcinoma
- (2019) Junqing Li et al. Diagnostic Pathology
- Tumour lineage shapes BRCA-mediated phenotypes
- (2019) Philip Jonsson et al. NATURE
- DNA double-strand break repair-pathway choice in somatic mammalian cells
- (2019) Ralph Scully et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Templated Insertions: A Smoking Gun for Polymerase Theta-Mediated End Joining
- (2019) Joost Schimmel et al. TRENDS IN GENETICS
- DAXX, as a Tumor Suppressor, Impacts DNA Damage Repair and Sensitizes BRCA-Proficient TNBC Cells to PARP Inhibitors
- (2019) Yaqin Shi et al. NEOPLASIA
- Revisiting Non-BRCA1/2 Familial Whole Exome Sequencing Datasets Implicates NCK1 as a Cancer Gene
- (2019) Jie Yin et al. Frontiers in Genetics
- Emerging Roles of RAD52 in Genome Maintenance
- (2019) Manisha Jalan et al. Cancers
- DNA-PK as an Emerging Therapeutic Target in Cancer
- (2019) Ismail S. Mohiuddin et al. Frontiers in Oncology
- Life or Death after a Break: What Determines the Choice?
- (2019) Lenno Krenning et al. MOLECULAR CELL
- Distinct roles of RAD52 and POLQ in chromosomal break repair and replication stress response
- (2019) Andrew A. Kelso et al. PLoS Genetics
- PARP Inhibitor Resistance: A Tug-of-War in BRCA-Mutated Cells
- (2019) Sylvie M. Noordermeer et al. TRENDS IN CELL BIOLOGY
- Genetic determinants of cellular addiction to DNA polymerase theta
- (2019) Wanjuan Feng et al. Nature Communications
- The MRE11–RAD50–NBS1 Complex Conducts the Orchestration of Damage Signaling and Outcomes to Stress in DNA Replication and Repair
- (2018) Aleem Syed et al. Annual Review of Biochemistry
- BRD4 Inhibition Is Synthetic Lethal with PARP Inhibitors through the Induction of Homologous Recombination Deficiency
- (2018) Chaoyang Sun et al. CANCER CELL
- Repair of DNA double-strand breaks by mammalian alternative end-joining pathways
- (2018) Annahita Sallmyr et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Homologous recombination and the repair of DNA double-strand breaks
- (2018) William Douglass Wright et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The DNA-PK Inhibitor VX-984 Enhances the Radiosensitivity of Glioblastoma Cells GrownIn Vitroand as Orthotopic Xenografts
- (2018) Cindy R. Timme et al. MOLECULAR CANCER THERAPEUTICS
- A Short BRCA2-Derived Cell-Penetrating Peptide Targets RAD51 Function and Confers Hypersensitivity toward PARP Inhibition
- (2018) Anika Trenner et al. MOLECULAR CANCER THERAPEUTICS
- Microhomology-mediated end joining: Good, bad and ugly
- (2018) Ja-Hwan Seol et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- Synthetic lethal therapies for cancer: what’s next after PARP inhibitors?
- (2018) Alan Ashworth et al. Nature Reviews Clinical Oncology
- Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas
- (2018) Theo A. Knijnenburg et al. Cell Reports
- Simultaneous Targeting of PARP1 and RAD52 Triggers Dual Synthetic Lethality in BRCA-Deficient Tumor Cells
- (2018) Katherine Sullivan-Reed et al. Cell Reports
- Combined ATR and DNA-PK Inhibition Radiosensitizes Tumor Cells Independently of Their p53 Status
- (2018) Hind Hafsi et al. Frontiers in Oncology
- Overexpression of the MRE11-RAD50-NBS1 (MRN) complex in rectal cancer correlates with poor response to neoadjuvant radiotherapy and prognosis
- (2018) Vincent Ho et al. BMC CANCER
- Mechanisms of PARP inhibitor sensitivity and resistance
- (2018) Alan D. D’Andrea DNA REPAIR
- Targeting Brd4 for cancer therapy: inhibitors and degraders
- (2018) Yingchao Duan et al. MedChemComm
- The therapeutic significance of mutational signatures from DNA repair deficiency in cancer
- (2018) Jennifer Ma et al. Nature Communications
- State-of-the-art strategies for targeting the DNA damage response in cancer
- (2018) Patrick G. Pilié et al. Nature Reviews Clinical Oncology
- Inactivation of DNA repair—prospects for boosting cancer immune surveillance
- (2018) Anna Truini et al. Genome Medicine
- RAD51 as a potential surrogate marker for DNA repair capacity in solid malignancies
- (2017) Mariam Gachechiladze et al. INTERNATIONAL JOURNAL OF CANCER
- Nonhomologous DNA end-joining for repair of DNA double-strand breaks
- (2017) Nicholas R. Pannunzio et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The helicase domain of Polθ counteracts RPA to promote alt-NHEJ
- (2017) Pedro A Mateos-Gomez et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- The homologous recombination protein RAD51 is a promising therapeutic target for cervical carcinoma
- (2017) Qian Chen et al. ONCOLOGY REPORTS
- The helicase domain of Polθ counteracts RPA to promote alt-NHEJ
- (2017) Pedro A Mateos-Gomez et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Functional and mutational landscapes of BRCA1 for homology-directed repair and therapy resistance
- (2017) Rachel W Anantha et al. eLife
- The BRCA1 Ubiquitin ligase function sets a new trend for remodelling in DNA repair
- (2017) Ruth M. Densham et al. Nucleus
- The BRCA1 Ubiquitin ligase function sets a new trend for remodelling in DNA repair
- (2017) Ruth M. Densham et al. Nucleus
- The Role of the Core Non-Homologous End Joining Factors in Carcinogenesis and Cancer
- (2017) et al. Cancers
- Dual TORK/DNA-PK inhibition blocks critical signaling pathways in chronic lymphocytic leukemia
- (2016) R. Thijssen et al. BLOOD
- A novel small molecule inhibitor of the DNA repair protein Ku70/80
- (2016) Eric Weterings et al. DNA REPAIR
- DNA polymerase θ (POLQ), double-strand break repair, and cancer
- (2016) Richard D. Wood et al. DNA REPAIR
- Targeting Homologous Recombination by Pharmacological Inhibitors Enhances the Killing Response of Glioblastoma Cells Treated with Alkylating Drugs
- (2016) N. Berte et al. MOLECULAR CANCER THERAPEUTICS
- Phosphorylated CtIP Functions as a Co-factor of the MRE11-RAD50-NBS1 Endonuclease in DNA End Resection
- (2016) Roopesh Anand et al. MOLECULAR CELL
- A role for human homologous recombination factors in suppressing microhomology-mediated end joining
- (2016) Sara Ahrabi et al. NUCLEIC ACIDS RESEARCH
- Targeting BRCA1- and BRCA2-deficient cells with RAD52 small molecule inhibitors
- (2016) Fei Huang et al. NUCLEIC ACIDS RESEARCH
- DNA repair targeted therapy: The past or future of cancer treatment?
- (2016) Navnath S. Gavande et al. PHARMACOLOGY & THERAPEUTICS
- Repair Pathway Choices and Consequences at the Double-Strand Break
- (2016) Raphael Ceccaldi et al. TRENDS IN CELL BIOLOGY
- Regulation of Single-Strand Annealing and its Role in Genome Maintenance
- (2016) Ragini Bhargava et al. TRENDS IN GENETICS
- Genomic landscape of DNA repair genes in cancer
- (2016) Young Kwang Chae et al. Oncotarget
- The DNA resection protein CtIP promotes mammary tumorigenesis
- (2016) Colleen R. Reczek et al. Oncotarget
- RAD51 inhibition in triple negative breast cancer cells is challenged by compensatory survival signaling and requires rational combination therapy
- (2016) Adrian P. Wiegmans et al. Oncotarget
- Small-molecule inhibitors identify the RAD52-ssDNA interaction as critical for recovery from replication stress and for survival of BRCA2 deficient cells
- (2016) Sarah R Hengel et al. eLife
- Targeting homologous recombination, new pre-clinical and clinical therapeutic combinations inhibiting RAD51
- (2015) Ambber Ward et al. CANCER TREATMENT REVIEWS
- DNA Double-Strand Break Repair Inhibitors as Cancer Therapeutics
- (2015) Mrinal Srivastava et al. CHEMISTRY & BIOLOGY
- Optimization of a Series of Triazole Containing Mammalian Target of Rapamycin (mTOR) Kinase Inhibitors and the Discovery of CC-115
- (2015) Deborah S. Mortensen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Targeting the DNA Damage Response in Cancer
- (2015) Mark J. O’Connor MOLECULAR CELL
- Homologous-recombination-deficient tumours are dependent on Polθ-mediated repair
- (2015) Raphael Ceccaldi et al. NATURE
- Mammalian polymerase θ promotes alternative NHEJ and suppresses recombination
- (2015) Pedro A. Mateos-Gomez et al. NATURE
- A mechanism for the suppression of homologous recombination in G1 cells
- (2015) Alexandre Orthwein et al. NATURE
- Mechanism of microhomology-mediated end-joining promoted by human DNA polymerase θ
- (2015) Tatiana Kent et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Mechanism of microhomology-mediated end-joining promoted by human DNA polymerase θ
- (2015) Tatiana Kent et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- The clinical impact of deficiency in DNA non-homologous end-joining
- (2014) Lisa Woodbine et al. DNA REPAIR
- 53BP1, BRCA1, and the Choice between Recombination and End Joining at DNA Double-Strand Breaks
- (2014) J. M. Daley et al. MOLECULAR AND CELLULAR BIOLOGY
- CtIP Maintains Stability at Common Fragile Sites and Inverted Repeats by End Resection-Independent Endonuclease Activity
- (2014) Hailong Wang et al. MOLECULAR CELL
- Catalytic and Noncatalytic Roles of the CtIP Endonuclease in Double-Strand Break End Resection
- (2014) Nodar Makharashvili et al. MOLECULAR CELL
- RPA antagonizes microhomology-mediated repair of DNA double-strand breaks
- (2014) Sarah K Deng et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Cancer-specific defects in DNA repair pathways as targets for personalized therapeutic approaches
- (2014) Felix Dietlein et al. TRENDS IN GENETICS
- Is Non-Homologous End-Joining Really an Inherently Error-Prone Process?
- (2014) Mireille Bétermier et al. PLoS Genetics
- Personalized synthetic lethality induced by targeting RAD52 in leukemias identified by gene mutation and expression profile
- (2013) K. Cramer-Morales et al. BLOOD
- A novel small molecule RAD51 inactivator overcomes imatinib-resistance in chronic myeloid leukaemia
- (2013) Jiewen Zhu et al. EMBO Molecular Medicine
- DNA Double-Strand Break Repair Pathway Choice Is Directed by Distinct MRE11 Nuclease Activities
- (2013) Atsushi Shibata et al. MOLECULAR CELL
- Microhomology-mediated End Joining and Homologous Recombination share the initial end resection step to repair DNA double-strand breaks in mammalian cells
- (2013) L. N. Truong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inhibition of BRCT(BRCA1)-phosphoprotein interaction enhances the cytotoxic effect of olaparib in breast cancer cells: a proof of concept study for synthetic lethal therapeutic option
- (2012) Ziyan Yuan Pessetto et al. BREAST CANCER RESEARCH AND TREATMENT
- An Optimized RAD51 Inhibitor That Disrupts Homologous Recombination without Requiring Michael Acceptor Reactivity
- (2012) Brian Budke et al. JOURNAL OF MEDICINAL CHEMISTRY
- Playing the End Game: DNA Double-Strand Break Repair Pathway Choice
- (2012) J. Ross Chapman et al. MOLECULAR CELL
- RI-1: a chemical inhibitor of RAD51 that disrupts homologous recombination in human cells
- (2012) Brian Budke et al. NUCLEIC ACIDS RESEARCH
- RAD52 inactivation is synthetically lethal with deficiencies in BRCA1 and PALB2 in addition to BRCA2 through RAD51-mediated homologous recombination
- (2012) B H Lok et al. ONCOGENE
- Identification of Specific Inhibitors of Human RAD51 Recombinase Using High-Throughput Screening
- (2011) Fei Huang et al. ACS Chemical Biology
- Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer Development
- (2011) Philip J. Stephens et al. CELL
- 53BP1 Inhibits Homologous Recombination in Brca1-Deficient Cells by Blocking Resection of DNA Breaks
- (2010) Samuel F. Bunting et al. CELL
- Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
- (2010) Andrew Tutt et al. LANCET
- Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
- (2010) M William Audeh et al. LANCET
- The DNA Damage Response: Making It Safe to Play with Knives
- (2010) Alberto Ciccia et al. MOLECULAR CELL
- An essential role for CtIP in chromosomal translocation formation through an alternative end-joining pathway
- (2010) Yu Zhang et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- DNA polymerase up-regulation is associated with poor survival in breast cancer, perturbs DNA replication, and promotes genetic instability
- (2010) F. Lemee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Rad52 inactivation is synthetically lethal with BRCA2 deficiency
- (2010) Z. Feng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Complex landscapes of somatic rearrangement in human breast cancer genomes
- (2009) Philip J. Stephens et al. NATURE
- Aberrations of the MRE11-RAD50-NBS1 DNA damage sensor complex in human breast cancer: MRE11 as a candidate familial cancer-predisposing gene
- (2008) Jirina Bartkova et al. Molecular Oncology
- A forward chemical genetic screen reveals an inhibitor of the Mre11–Rad50–Nbs1 complex
- (2008) Aude Dupré et al. Nature Chemical Biology
- Alternative-NHEJ Is a Mechanistically Distinct Pathway of Mammalian Chromosome Break Repair
- (2008) Nicole Bennardo et al. PLoS Genetics
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started